According to the article “The Immune Landscape of Cancer” published in the journal Immunity in 2018, an immunogenicity analysis of 33 cancers in TCGA was performed, and all tumours were classified into six immune subtypes, namely, wound healing (Immune C1), IFN-dominant (Immune C2), inflammatory (Immune C3), lymphocyte depleted (Immune C4), immunologically quiet (Immune C5) and TGF-dominant (Immune C6) [35]. The gene discussed is IFNA1; the disease is cancer.